- Home
- Articles
- latamerica
- inflammatory disorder
Refine by
Inflammatory Disorder Articles & Analysis
12 articles found
These chemokines protein allows researchers to study the functional dynamics of chemokine-receptor interactions in controlled environments, facilitating the development of targeted therapies for a range of diseases, including cancer, autoimmune disorders, and chronic inflammatory conditions. One of the most significant applications lies in cancer immunotherapy. ...
This process also aids in screening for monoclonal antibodies with high specificity and affinity, crucial for therapeutic applications in oncology, infectious diseases, and autoimmune disorders. 4. Glycan-Based Drug Discovery The study of glycan structures has led to the discovery of novel drug candidates targeting glycan-related pathways. ...
The versatility of nanobodies has led to the development of a wide range of nanobody-based drug delivery systems for various diseases, including cancer, infectious diseases, and inflammatory disorders. For example, nanobodies have been used to deliver anti-inflammatory drugs to inflamed tissues, resulting in reduced inflammation and tissue ...
Functionally, TREM1 acts as an amplifier of inflammatory responses. Upon activation, it potentiates the production of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6), thereby exacerbating the inflammatory cascade. ...
The high selectivity, resistance-overcoming capabilities, and ability to target previously undruggable proteins make PROTACs effective in various diseases, including neurological disorders, inflammatory diseases, and cancer. Peptide-Based SM-PROTAC Traditional PROTACs are linear structures that connect target protein ligands and E3 ligands with suitable linkers. ...
They induce the production of inflammatory mediators, increase vascular permeability, and promote the recruitment of immune cells to the site of inflammation. ...
This disturbance shifts the local microenvironment towards a pro-inflammatory state, resulting in tissue damage and the emergence of systemic immune disorders. ...
The prevalence of AF in HFpEF ranges from 15% to 40%,[26,27,28,29] and it seems to implicate a worse prognosis in patients with HFpEF than HFrEF.[30] If both heart failure and AF coexist, the risk for worse outcomes and hospitalizations increases significantly, with a two-fold increase in mortality.[31] AF and HFpEF appear to both be manifestations of a common underlying atrial and ventricular ...
In honor of National Fibromyalgia Awareness Day this month, we are doing our part to set the record straight on Fibromyalgia, a condition the MayoClinic calls “one of the most misunderstood disorders in medicine today.” Once thought to be an autoimmune or inflammatory disorder, specialists now agree that fibromyalgia is a ...
Secukinumab, an IL-17A sequestering agent used in treating psoriasis, was selected as a repurposed candidate to address the sequential inflammatory disorders that follow the first metabolic insult. Conclusions Our analysis suggests this novel combinatorial therapeutic approach inducing DPP4 and Il-17a suppression has a high likelihood of ameliorating a ...
HBOT is a very effective adjunctive treatment for Rheumatoid Arthritis procedures Rheumatoid arthritis is a chronic inflammatory autoimmune disorder that can affect the lining of the joints and cause painful swelling that will result in the erosion of bones and the deformation of joints, which aggravated, leads to physical disabilities. As an autoimmune ...
Combined Low-Dose Radon- and Hyperthermia Therapy (LDRnHT) causes pain reduction in patients with AS and induces the cytokine transforming growth factor-β1 (TGF-β1). TGF-β1 acts as an anti-inflammatory cytokine and influences the OPG/RANK/RANKL system. We therefore performed a study on 33 AS patients to investigate the effect of LDRnHT on serum levels of bone metabolism markers ...